PAVmed Inc.
PAVmed Inc. (PAVM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PAVM · as of Jun 8, 2026
Key Statistics
Explore PAVmed Inc. Data
pavm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
Competitors & Peers
pavm competitorsPAVM
ADVB
APVO
BMRA
BNR
DHAIStock Performance
Full HistoryAbout PAVmed Inc.
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings…
what is pavmed inc. · pavm stock overview · pavmed inc. company profile · who is pavmed inc. ceo · pavm NASDAQ · pavmed inc. headquarters · pavmed inc. business segments
About Stock Overview & Key Data
PAVmed Inc. (PAVM) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 27, 2016. As of the latest trading session, PAVM stock price is $5.18, with a market capitalization of $2.8M. The stock has returned -73.12% over the past 12 months and -21.75% year-to-date.
According to 3 Wall Street analysts, the consensus rating for PAVmed Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, PAVmed Inc. reported revenue of $71000.00 and net income of $401000.00. For detailed data — including PAVmed Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, PAVmed Inc. (PAVM) stock price is $5.18. The stock is traded on NASDAQ under the ticker symbol PAVM. The 52-week range is $5.10 – $28.44.